Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary Lou Orcutt is active.

Publication


Featured researches published by Mary Lou Orcutt.


Genomics | 1990

Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3

Shigeto Hosoe; Hiltrud Brauch; Farida Latif; Gladys M. Glenn; Gambert Daniel; Sherri J. Bale; Peter L. Choyke; Michael B. Gorin; Edward H. Oldfield; Arlene Berman; Jack Goodman; Mary Lou Orcutt; K. Hampsch; John Dllisio; William S. Modi; Wesley McBride; Patrick Anglard; Gary Weiss; McClellan M. Walther; W. Marston Linehan; Michael I. Lerman; Berton Zbar

We studied 25 families with von Hippel-Lindau disease (VHL) to locate VHL more precisely on chromosome 3. We found that VHL was linked to RAF1, confirming previous observations, and to two polymorphic DNA markers, D3S18 and D3S191. Multipoint linkage analysis indicated that the most likely location for VHL was in the interval between RAF1 and D3S18. D3S18 was located at 3p26. Genetic heterogeneity was not detected in this panel of von Hippel-Lindau disease families. The polymorphic markers RAF1, D3S18, and D3S191 should be useful in identifying asymptomatic gene carriers in VHL families and in guiding efforts at gene isolation.


Human Genetics | 1993

Von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis

Masahiro Yao; Farida Latif; Mary Lou Orcutt; Igor Kuzmin; Thomas Stackhouse; Fang wei Zhou; Kalman Tory; Fuh Mei Duh; Frances M. Richards; Eamonn R. Maher; Sal LaForgia; Kay Huebner; Denis Le Pasilier; Marston Linehan; Michael I. Lerman; Berton Zbar

Von Hippel-Lindau disease (VHL) is an inherited multisystem neoplastic disorder. We prepared a 2.5-megabase (Mb) restriction map of the region surrounding the VHL gene and identified and characterized overlapping deletions in three unrelated patients affected with VHL. The smallest nested deletion (100 kb) was located within a 510-kb NruI fragment detected by 19–63′. The rearrangements detected will be useful in isolating and evaluating candidate cDNAs for the VHL gene. The detailed physical map will be useful in studying the organization and structure of genes in the VHL region.


Human Genetics | 1991

Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes

Michael I. Lerman; Farida Latif; Gladys M. Glenn; Lambert N. Daniel; Hiltrud Brauch; Shigeto Hosoe; K. Hampsch; J. Delisio; Mary Lou Orcutt; O.Wesley McBride; Karl-Heinz Grzeschik; Takashi Takahashi; John D. Minna; Patrick Anglard; W. Marston Linehan; Berton Zbar

SummaryA collection of 2,000 lambda phage-carrying human single-copy inserts (> 700 bp) were isolated from two chromosome-3 flow-sorted libraries. The single-copy DNA fragments were first sorted into 3p and 3q locations and about 700 3p fragments were regionally mapped using a deletion mapping panel comprised of two humanhamster and two-human-mouse cell hybrids, each containing a chromosome 3 with different deletions in the short arm. The hybrids were extensively mapped with a set of standard 3p markers physically localized or ordered by linkage. The deletion mapping panel divided the short arm into five distinct subregions (A-E). The 3p fragments were distributed on 3p regions as follows: region A, 26%; B, 31%; C, 4%; D, 4% and E, 35%. We screened 300 single-copy DNA fragments from the distal part of 3p (regions A and B) with ten restriction endonucleases for their ability to detect restriction fragment length polymorphisms (RFLPs). Of these fragments 110 (36%) were found to detect useful RFLPs: 35% detected polymorphisms with frequency of heterozygosity of 40% or higher, and 25% with frequency of 30% or higher. All polymorphisms originated from single loci and most of them were of the base pair substitution type. These RFLP markers make it possible to construct a fine linkage map that will span the distal part of chromosome 3p and encompasses the von Hippel-Lindau disease locus. The large number of single-copy fragments (2,000) spaced every 100–150 kb on chromosome 3 will make a significant contribution to mapping and sequencing the entire chromosome 3. The 300 conserved chromosome 3 probes will increase the existing knowledge of man-mouse homologies.


Human Genetics | 1992

Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3

Farida Latif; William S. Modi; Fuh-Mei Duh; Laura S. Schmidt; Hua Li; L. Geil; Mary Lou Orcutt; Amanda Heppell-Parton; Pamela Rabbitts; W. Marston Linehan; Berton Zbar; Michael I. Lerman

SummaryGenetic markers with high degrees of polymorphisms are of vital importance in the construction of high resolution (2–4 cM) linkage maps of human chromosomes as specified in the short-term goals of the Human Genome Initiative. In this paper, we report on molecular and genetic characterization and physical localization of 11 new multiallele restriction fragment length polymorphism markers on human chromosome 3p. Ten of these represent three- and four-allele polymorphisms of the base substitution type probably at two adjacent restriction sites. One has been identified as a novel minisatellite sequence comprising a variable copy number tandem repeat array of a G/T-rich 79-bp sequence. This collection of multiallele polymorphic (PIC values: 0.40–0.60) markers should prove valuable and increase the resolution power of the available chromosome 3p genetic markers.


Nature Genetics | 1997

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.

Laura S. Schmidt; Fuh-Mei Duh; Fan Chen; Takeshi Kishida; Gladys M. Glenn; Peter L. Choyke; Stephen W. Scherer; Zhenping Zhuang; Irina A. Lubensky; Michael Dean; Rando Allikmets; Abi Chidambaram; Ulf S.R. Bergerheim; J. Timothy Feltis; Carme Casadevall; Agustín Zamarrón; Marta Bernués; Stéphane Richard; C.J.M. Lips; McClellan M. Walther; Lap-Chee Tsui; L. Geil; Mary Lou Orcutt; Thomas Stackhouse; Jami Lipan; Leah Slife; Hiltrud Brauch; Jochen Decker; Gloria Niehans; Michael D. Hughson


Human Mutation | 1995

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Fan Chen; Takeshi Kishida; Masahiro Yao; Thomas Hustad; Damjan Glavač; Michael Dean; James R. Gnarra; Mary Lou Orcutt; Fuh Mei Duh; Gladys M. Glenn; Jane Green; Y. Edward Hsia; James M. Lamiell; Hua Li; Ming Hui Wei; Laura S. Schmidt; Kalman Tory; Igor Kuzmin; Tom Stackhouse; Farida Latif; W. Marston Linehan; Michael I. Lerman; Berton Zbar


The Journal of Urology | 1998

Germline and Somatic Mutations in the Tyrosine Kinase Domain of the MET Proto-Oncogene in Papillary Renal Carcinomas

Laura S. Schmidt; Fuh Mei Duh; Fan Chen; Takeshi Kishida; Gladys M. Glenn; Peter L. Choyke; Stephen W. Scherer; Z. Zhuang; Irina A. Lubensky; Michael Dean; Rando Allikmets; Abirami Chidambaram; Ulf S.R. Bergerheim; J.T. Feltis; Carme Casadevall; Agustín Zamarrón; Marta Bernués; Stéphane Richard; C.J.M. Lips; McClellan M. Walther; Lap-Chee Tsui; L. Geil; Mary Lou Orcutt; Thomas Stackhouse; J. Lipan; L. Slife; Hiltrud Brauch; Jochen Decker; G. Niehans; M.D. Hughson


Cancer Research | 1995

Suppression of Growth of Renal Carcinoma Cells by the von Hippel-Lindau Tumor Suppressor Gene

Fan Chen; Takeshi Kishida; Fuh-Mei Duh; Paul Renbaum; Mary Lou Orcutt; Laura S. Schmidt; Berton Zbar


Cancer Research | 1992

Chromosome 3p Deletions in Head and Neck Carcinomas: Statistical Ascertainment of Allelic Loss

Farida Latif; Matthew J. Fivash; Gladys M. Glenn; Kalman Tory; Mary Lou Orcutt; K. Hampsch; J. Delisio; Michael I. Lerman; Janet M. Cowan; Michael A. Beckett; Ralph R. Weichselbaum


Cancer Research | 1993

Von Hippel-Lindau Syndrome: Cloning and Identification of the Plasma Membrane Ca+ +-transporting ATPase Isoform 2 Gene That Resides in the Von Hippel-Lindau Gene Region

Farida Latif; Fuh-Mei Duh; James R. Gnarra; Kalman Tory; Igor Kuzmin; Masahiro Yao; Thomas Stackhouse; William S. Modi; L. Geil; Laura S. Schmidt; Hua Li; Mary Lou Orcutt; Eamonn R. Maher; Frances M. Richards; Maude E. Phipps; Malcolm A. Ferguson-Smith; Denis Le Paslier; W. Marston Linehan; Berton Zbar; Michael I. Lerman

Collaboration


Dive into the Mary Lou Orcutt's collaboration.

Top Co-Authors

Avatar

Berton Zbar

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michael I. Lerman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gladys M. Glenn

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

F. Latif

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L. Geil

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Masahiro Yao

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

W. Rayford

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Farida Latif

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Lambert N. Daniel

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge